Search

Search Results

• Necessity of cooperation on pharmaceutical and biotechnology development processes in the Northern Great Plain region

  30-46

  Balázs Kiss

  Dávid Domonkos

  János Felföldi

  Views:

  39

  One of the leading sectors of the Hungarian Northern Great Plain region - a high capital-intensive, long-return, "high risk - high benefit" industry such as red biotechnology – was examined to see what impact its development might have and what expectations the various cooperation opportunities set for the value chain at different points. It can be stated that the industry has serious, decades-long roots in the region. At the same time, following the spiral of the "biotech industry" also comes with new challenges, and a modern, innovative university background is essential for the expansion of the sector and its establishment at all. In the 2020s, new competitors arrived, such as the vehicle and battery industries, which are also high value-added and innovation-intensive industries. In all these areas, industry clusters have been formed, with universities of the region as intellectual hubs. Along these lines, the innovation mechanisms and collaborations of the respective disciplines (biotechnology in this publication) have been renewed, modernised and strengthened, which is also important for managing risks.

• Examining macro factors influencing human capital investment decisions in the pharmaceutical industry

  10-20

  Gergő Tömöri

  Views:

  52

  The innovation policies of the pharmaceutical industry are determined mainly by elements of the macro-environment that influence the strategic directions of the companies. In this context, the study aimed to examine whether and to what extent determined the expansion or reduction of the workforce of pharmaceutical companies in the last decade by macro-environmental indicators. These indicators represent the political, economic, social and technological innovation environment well, which are also considered their strategic decisions. The analysis was based on sectoral and macroeconomic indicators and industry employment data for 27 European countries. The results of the multivariate statistical analysis show that the economic potential of each country's uptake market, the volume of governmental support, and the human development index significantly influenced the evolution of pharmaceutical employment over the period under study.